LEO to buy dermatology brands from Astellas

11 November 2015 - Deborah Wilkes

Archived

LEO Pharma is set to acquire Astellas Pharma's global dermatology portfolio, including Locobase for treating dry skin, for €675 million (US$725 million).

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: